Concepedia

Igor Oyarzabal Perez

IO

Statistics

Publications

2

Citations

108

H-Index

2

Active since

2015

Affiliations

St. Antonius Ziekenhuis(Current)

GlaxoSmithKline (Spain)

The University of Texas Southwestern Medical Center

Clinical Emergency Hospital Bucharest

Research Triangle Park Foundation

Igor Oyarzabal Perez is an author at St. Antonius Ziekenhuis specializing in pharmacotherapy, prostate disorders, and medicine.

Publications per year

2015–2016

2

Publications

2

Efficacy and safety of a fixed‐dose combination of dutasteride and tamsulosin treatment ( <scp>D</scp> uodart <sup>®</sup> ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment‐naïve men with moderately symptomatic benign prostatic hyperplasia: 2‐year <scp>CONDUCT</scp> study results

Claus G. Roehrborn, Igor Oyarzabal Perez, Erik P.M. Roos et al. · British Journal of Urology · 2015 · 94 citations · Full text

, , +12

Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study

Claus G. Roehrborn, Igor Oyarzabal Perez, Erik P.M. Roos et al. · World Journal of Urology · 2016 · 14 citations · Full text

, , +10

1–2 of 2